Clinical Trials · NCT00426153
Octreotide in Severe Polycystic Liver Disease
- Phase
- Phase 2/Phase 3
- Recruitment status
- Completed
- Sponsor
- Mayo Clinic
- Enrollment
- 42
- Start date
- Jan 2007
- Locations
- 1 site, United States
- Primary endpoint
- Percent Change in Liver Volume